Durata Offers New Data for DALVANCE, Patients Given DALVANCE Showed Fewer Adverse Events
October 10, 2014 at 13:40 PM EDT
Durata Therapeutics (Nasdaq: DRTX) today announced a summary of presentation data from its recently launched product, DALVANCE™ ...
